Price T Rowe Associates Inc Chimerix Inc Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.19 - $2.09 $1,066 - $1,872	896 Added 6.27%	15,175 $20,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $25,844 - $39,410	14,279 New	14,279 $28,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $9.7 Million - $14.3 Million	-1,632,612 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.54 - $9.79 $801,177 - $1.04 Million	-106,257 Reduced 6.11%	1,632,612 $13.1 Million
Q1 2021 May 17, 2021	BUY	$4.76 - $11.25 $8.28 Million - $19.6 Million	1,738,869 New	1,738,869 $16.8 Million

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $79.7M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.